NASDAQ · Biotechnology

PepGen Inc. (PEPG) Stock

$2.62 +10.08% NASDAQ: PEPG Healthcare

Valuation

MetricValue
Price$2.62
Market Cap$181.22M
P/E Ratio-1.52
P/B Ratio1.32
P/S Ratio0.00
EPS (TTM)$-2.12
52-Week High$7.80
52-Week Low$1.31
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-51.01%
ROA-50.88%
ROCE-57.59%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.13
Current Ratio11.62

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-27.0M$-68.0M$-85.0M$-98.0M$-94.0M
Net Profit$-27.0M$-69.0M$-79.0M$-90.0M$-90.0M
EPS$-1.22$-4.42$-3.30$-2.85$-2.12
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$144.0M$217.0M$143.0M$151.0M$174.0M
Total Liabilities$11.0M$38.0M$35.0M$32.0M$26.0M
Cash$133.0M$182.0M$81.0M$49.0M$61.0M
Borrowings$0$25.0M$20.0M$19.0M$17.0M

Latest News

Craig-Hallum Initiates PepGen at Buy With $11 Price Target MT Newswires · Jun 16, 2026 PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks · May 20, 2026 PepGen Files $400 Million Mixed Shelf MT Newswires · May 19, 2026 Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now? Insider Monkey · May 18, 2026 PepGen (PEPG) Upgraded to Buy: Here's What You Should Know Zacks · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-23.0M$-59.0M$-69.0M$-82.0M$-82.0M
Investing Cash Flow$-1.0M$-8.0M$-35.0M$-38.0M$-15.0M
Financing Cash Flow$-1.0M$-2.0M$0$-1.0M$0
Net Cash Flow$125.0M$49.0M$-101.0M$-31.0M$11.0M
Free Cash Flow$-23.0M$-63.0M$-72.0M$-83.0M$-82.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-2.23
FCF Yield-44.05%
Quick Ratio13.36
Interest Coverage0.00
Return 1Y89.15%
Return 3Y-69.73%
Return 5Y—

Ownership

Insiders Held0.23%
Institutions Held88.37%
Institutions Float Held88.58%
Institutional HolderSharesReport Date
RA Capital Management, L.P.20,064,5452026-03-31
Commodore Capital Lp4,475,0002026-03-31
Viking Global Investors, L.P.3,482,4342026-03-31
Laurion Capital Management, LP2,750,8552026-03-31
Vivo Capital, LLC2,325,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALECAlector, Inc. $2.08 +2.97% -1.84 $230.93M 0.00%
APLTApplied Therapeutics, Inc. $0.10 +0.00% -0.24 $14.86M 0.00%
CRBPCorbus Pharmaceuticals Holdings, Inc. $5.38 +2.09% -0.95 $99.68M 0.00%
CRDFCardiff Oncology, Inc. $1.08 +1.89% -1.87 $83.24M 0.00%
CYBNCybin Inc. $8.28 +1.22% -1.67 $413.02M 0.00%

About PepGen Inc.

PepGen Inc. is led by CEO James G. McArthur, employs 79 people, headquartered in US, publicly traded since 2022.

PepGen Inc. (PEPG) stock trades at $2.62 with a market capitalization of $181.22M. The stock is valued at a price-to-earnings (P/E) ratio of -1.52, price-to-book of 1.32, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.31 and $7.80, and currently trades 66.4% below its 52-week high.

On profitability, PepGen Inc. generates a return on equity (ROE) of -51.01%, return on capital employed of -57.59%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides